Gamelin Erick Insider Trades

Insider Trading History

Track insider trading activity for Gamelin Erick. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Chief Development Officer
Holding Value $113k 52,992 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$63.7k 38,584 shares
$1.65
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Chief Development Officer
Holding Value $30.7k 14,408 shares
Last Trade
May 14, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$776 404 shares
$1.92
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Chief Development Officer
Holding Value $202k 94,946 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$143k 94,946 shares
$1.51
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Chief Development Officer
Holding Value $31.5k 14,812 shares
Last Trade
Feb 14, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$768 471 shares
$1.63
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Chief Development Officer
Holding Value $32.6k 15,283 shares
Last Trade
Nov 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$903 403 shares
$2.24
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Chief Development Officer
Holding Value $33.4k 15,686 shares
Last Trade
Aug 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$560 403 shares
$1.39
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Chief Development Officer
Holding Value $34.3k 16,089 shares
Last Trade
May 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$459 403 shares
$1.14
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Chief Development Officer
Holding Value $166k 78,078 shares
Last Trade
Mar 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$415k 78,078 shares
$5.31
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Chief Development Officer
Holding Value $35.1k 16,492 shares
Last Trade
Feb 14, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.54k 469 shares
$5.42
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Chief Development Officer
Holding Value $36.1k 16,961 shares
Last Trade
Nov 14, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.18k 402 shares
$7.92
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Chief Development Officer
Holding Value $37k 17,363 shares
Last Trade
Aug 14, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.82k 402 shares
$7.02
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Chief Development Officer
Holding Value $37.8k 17,765 shares
Last Trade
May 14, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.36k 402 shares
$8.36
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Chief Development Officer
Holding Value $95.9k 45,045 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$257k 45,045 shares
$5.70
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Chief Development Officer
Holding Value $38.7k 18,167 shares
Last Trade
Feb 14, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.59k 468 shares
$3.40
$2.13
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Chief Medical Officer
Holding Value $39.7k 18,635 shares
Last Trade
Nov 14, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$7.09k 1,395 shares
$5.08
$2.13

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up